Aldeyra Therapeutics, Inc. (ALDX)
5.615
+0.16
(+2.84%)
USD |
NASDAQ |
Mar 02, 16:00
5.53
-0.08
(-1.51%)
After-Hours: 19:22
Aldeyra Therapeutics Research and Development Expense (TTM) : 25.66M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Assertio Holdings, Inc. | 2.49M |
| MediciNova, Inc. | 7.098M |
| Altimmune, Inc. | 67.72M |
| AbbVie, Inc. | 9.096B |
| Actinium Pharmaceuticals, Inc. | 20.82M |